On the safety of intravenous iron, evidence trumps conjecture.
作者信息
Auerbach Michael, Adamson John, Bircher Andreas, Breymann Christian, Fishbane Steven, Gafter-Gvili Anat, Gasche Christoph, Gilreath Jeffrey, Grazzini Giuliano, Henry David, Liumbruno Giancarlo, Locatelli Francesco, Macdougall Iain, Munoz Manuel, Rampton David, Rodgers George, Shander Aryeh
机构信息
Georgetown University, Washington DC, WA, USA
University of California San Diego, San Diego, CA, USA.
出版信息
Haematologica. 2015 May;100(5):e214-5. doi: 10.3324/haematol.2014.121004.
Abstract
摘要
相似文献
1
On the safety of intravenous iron, evidence trumps conjecture.关于静脉注射铁剂的安全性，证据胜过猜测。
Haematologica. 2015 May;100(5):e214-5. doi: 10.3324/haematol.2014.121004.
2
SAFETY AND EFFICACY OF INTRAVENOUS ADMINISTRATION OF IRON PREPARATIONS.
Acta Pol Pharm. 2017 Jan;74(1):13-24.
3
Intravenous iron: the iatrogenic kick to lose control over oxygen?
Kidney Blood Press Res. 2002;25(5):284-8. doi: 10.1159/000066793.
4
Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil.静脉注射蔗糖铁与口服铁剂用于减肥后腹壁成形术后贫血的术后治疗：巴西一项开放标签、随机、优效性试验
Lancet Haematol. 2018 Jul;5(7):e310-e320. doi: 10.1016/S2352-3026(18)30071-1.
5
Lost without directions: lessons from the anemia debate and the drive study.迷失方向：贫血辩论与驱动研究的教训
Clin J Am Soc Nephrol. 2009 May;4(5):1009-10. doi: 10.2215/CJN.00270109. Epub 2009 Apr 8.
6
Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.铁剂在透析患者贫血治疗中的应用：对促红细胞生成素的重要支持。
Int J Artif Organs. 1998 Nov;21(11):681-6.
7
Long-term risks of increased use of intravenous iron.
Lancet. 2007 Aug 11;370(9586):482; author reply 482-3. doi: 10.1016/S0140-6736(07)61226-4.
8
Iron supplementation in renal anemia.肾性贫血中的铁补充治疗
Semin Nephrol. 2006 Jul;26(4):319-24. doi: 10.1016/j.semnephrol.2006.05.009.
9
High dose intravenous iron: a note of caution.
Nephrol Dial Transplant. 2002 Jun;17(6):962-5. doi: 10.1093/ndt/17.6.962.
10
The available intravenous iron formulations: History, efficacy, and toxicology.可用的静脉铁制剂：历史、疗效及毒理学
Hemodial Int. 2017 Jun;21 Suppl 1:S83-S92. doi: 10.1111/hdi.12560. Epub 2017 Mar 29.
引用本文的文献
1
Intravenous administration of ferric derisomaltose is associated with a higher incidence of infusion reactions than ferric carboxymaltose, and unaffected by dilution volume.与羧基麦芽糖铁相比，静脉注射异麦芽糖铁引发输液反应的发生率更高，且不受稀释体积的影响。
Intern Med J. 2025 Aug;55(8):1293-1300. doi: 10.1111/imj.70100. Epub 2025 Jun 4.
2
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia.缺铁和缺铁性贫血的诊断、治疗及预防建议。
Hemasphere. 2024 Jul 15;8(7):e108. doi: 10.1002/hem3.108. eCollection 2024 Jul.
3
How Does Iron Deficiency Anemia Impact Outcomes following Revision Total Hip Arthroplasty?缺铁性贫血如何影响翻修全髋关节置换术后的结果？
Hip Pelvis. 2021 Sep;33(3):140-146. doi: 10.5371/hp.2021.33.3.140. Epub 2021 Sep 6.
4
Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study.非血液透析慢性肾脏病患者使用羧麦芽糖铁：一项纵向队列研究
J Clin Med. 2021 Mar 23;10(6):1322. doi: 10.3390/jcm10061322.
5
Iron deficiency without anaemia: a diagnosis that matters.缺铁而不贫血：一个重要的诊断。
Clin Med (Lond). 2021 Mar;21(2):107-113. doi: 10.7861/clinmed.2020-0582.
6
Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice.缺铁治疗选择及静脉铁在常规临床实践中应用的问答
Ann Med. 2021 Dec;53(1):274-285. doi: 10.1080/07853890.2020.1867323.
7
Intravenous ferric carboxymaltose is effective and safe in patients with inflammatory rheumatic diseases.静脉注射羧基麦芽糖铁在炎症性风湿病患者中有效且安全。
Blood Transfus. 2020 May;18(3):176-181. doi: 10.2450/2019.0207-19. Epub 2019 Dec 13.
8
Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs.急诊科早期静脉补铁可减少红细胞单位输注、住院、再次输血、住院时间和费用。
Blood Transfus. 2020 Mar;18(2):106-116. doi: 10.2450/2019.0248-19. Epub 2019 Dec 17.
9
Patient Blood Management: a revolutionary approach to transfusion medicine.患者血液管理：输血医学的革命性方法。
Blood Transfus. 2019 May;17(3):191-195. doi: 10.2450/2019.0109-19.
10
Prevention and management of acute reactions to intravenous iron in surgical patients.手术患者静脉铁剂急性反应的预防和处理。
Blood Transfus. 2019 Mar;17(2):137-145. doi: 10.2450/2018.0156-18. Epub 2018 Oct 16.
本文引用的文献
1
Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancy.静脉注射羧麦芽糖铁（Ferinject）和氢氧化铁右旋糖酐（Cosmofer）在孕期的疗效和安全性比较
Obstet Med. 2012 Sep;5(3):105-7. doi: 10.1258/om.2012.110095. Epub 2012 Apr 23.
2
The safety of intravenous iron preparations: systematic review and meta-analysis.静脉铁制剂的安全性：系统评价和荟萃分析。
Mayo Clin Proc. 2015 Jan;90(1):12-23. doi: 10.1016/j.mayocp.2014.10.007. Epub 2014 Oct 30.
3
Hypersensitivity from intravenous iron products.静脉注射铁剂产品引起的超敏反应。
Immunol Allergy Clin North Am. 2014 Aug;34(3):707-23, x-xi. doi: 10.1016/j.iac.2014.04.013.
4
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.非达霉素与蔗糖铁治疗慢性肾脏病患者缺铁性贫血的随机对照研究
Clin J Am Soc Nephrol. 2014 Apr;9(4):705-12. doi: 10.2215/CJN.05320513. Epub 2014 Jan 23.
5
A systematic analysis of global anemia burden from 1990 to 2010.1990 年至 2010 年全球贫血负担的系统分析。
Blood. 2014 Jan 30;123(5):615-24. doi: 10.1182/blood-2013-06-508325. Epub 2013 Dec 2.
6
Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia.羧基麦芽糖铁与右旋糖酐铁治疗缺铁性贫血患者安全性和有效性的直接比较
Anemia. 2013;2013:169107. doi: 10.1155/2013/169107. Epub 2013 Aug 29.
7
Comparative rates of adverse events with different formulations of intravenous iron.不同静脉铁制剂不良事件发生率的比较。
Am J Hematol. 2012 Nov;87(11):E123-4. doi: 10.1002/ajh.23322. Epub 2012 Sep 11.
8
Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.快速静脉滴注（1小时）1克低分子右旋糖酐铁（INFeD）治疗缺铁性贫血的安全性和有效性。
Am J Hematol. 2011 Oct;86(10):860-2. doi: 10.1002/ajh.22153. Epub 2011 Aug 29.
9
Use of parenteral iron products and serious anaphylactic-type reactions.静脉用铁剂产品的使用与严重过敏样反应。
Am J Hematol. 2010 Sep;85(9):650-4. doi: 10.1002/ajh.21794.
10
High-molecular weight iron dextran: a wolf in sheep's clothing?高分子量右旋糖酐铁：披着羊皮的狼？
J Am Soc Nephrol. 2008 May;19(5):833-4. doi: 10.1681/ASN.2008030255. Epub 2008 Mar 27.
Zotero 插件